MOREPEN LABORATORIES
Quarterly Results Analysis [Jun2024]
MOREPEN LABORATORIES Quarterly Results
Consolidated | Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹455 Cr | ₹423 Cr | ₹445 Cr | ₹422 Cr | ₹401 Cr | ₹364 Cr | ₹348 Cr | ₹403 Cr |
Expenses | ₹404 Cr | ₹375 Cr | ₹394 Cr | ₹388 Cr | ₹375 Cr | ₹348 Cr | ₹328 Cr | ₹374 Cr |
Operating Income | ₹52 Cr | ₹48 Cr | ₹51 Cr | ₹34 Cr | ₹26 Cr | ₹16 Cr | ₹21 Cr | ₹29 Cr |
Other Income | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr |
Depreciation | ₹6 Cr | ₹10 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr |
Profit Before Tax | ₹48 Cr | ₹42 Cr | ₹44 Cr | ₹29 Cr | ₹21 Cr | ₹11 Cr | ₹14 Cr | ₹22 Cr |
Profit After Tax | ₹36 Cr | ₹29 Cr | ₹32 Cr | ₹21 Cr | ₹15 Cr | ₹8 Cr | ₹9 Cr | ₹16 Cr |
EPS | ₹0.71 | ₹0.55 | ₹0.63 | ₹0.42 | ₹0.29 | ₹0.16 | ₹0.18 | ₹0.31 |
Industry Peers & Returns | 1W | 1M | 1Y |
MOREPEN LABORATORIES | 9.5% | 47.2% | 141.2% |
SUN PHARMACEUTICAL INDUSTRIES | 0.4% | 5.1% | 64.6% |
CIPLA | -2.1% | 3.7% | 30.8% |
DR REDDYS LABORATORIES | -2.9% | -3.7% | 20.1% |
ZYDUS LIFESCIENCES | -1% | -13.6% | 81.7% |
DIVIS LABORATORIES | 2.1% | 3.9% | 42.8% |
MOREPEN LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 7.60 % |
Y-o-Y | 13.51 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2024 | ₹455 Cr | 7.60 | |
Mar2024 | ₹423 Cr | -4.83 | |
Dec2023 | ₹445 Cr | 5.40 | |
Sep2023 | ₹422 Cr | 5.17 | |
Jun2023 | ₹401 Cr | 10.27 | |
Mar2023 | ₹364 Cr | 4.37 | |
Dec2022 | ₹348 Cr | -13.53 | |
Sep2022 | ₹403 Cr | - |
MOREPEN LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 6.70 % |
Y-o-Y | 97.87 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2024 | ₹52 Cr | 6.70 | |
Mar2024 | ₹48 Cr | -4.33 | |
Dec2023 | ₹51 Cr | 50.54 | |
Sep2023 | ₹34 Cr | 28.76 | |
Jun2023 | ₹26 Cr | 67.68 | |
Mar2023 | ₹16 Cr | -24.18 | |
Dec2022 | ₹21 Cr | -29.02 | |
Sep2022 | ₹29 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -0.87 % |
Y-o-Y | 74.19 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2024 | 11.34% | -0.87 | |
Mar2024 | 11.44% | 0.62 | |
Dec2023 | 11.37% | 42.84 | |
Sep2023 | 7.96% | 22.27 | |
Jun2023 | 6.51% | 52.10 | |
Mar2023 | 4.28% | -27.33 | |
Dec2022 | 5.89% | -17.85 | |
Sep2022 | 7.17% | - |
MOREPEN LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 25.85 % |
Y-o-Y | 147.19 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2024 | ₹36 Cr | 25.85 | |
Mar2024 | ₹29 Cr | -10.17 | |
Dec2023 | ₹32 Cr | 50.50 | |
Sep2023 | ₹21 Cr | 45.27 | |
Jun2023 | ₹15 Cr | 77.55 | |
Mar2023 | ₹8 Cr | -8.37 | |
Dec2022 | ₹9 Cr | -43.11 | |
Sep2022 | ₹16 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 17.08 % |
Y-o-Y | 117.81 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2024 | 7.95 % | 17.08 | |
Mar2024 | 6.79 % | -5.69 | |
Dec2023 | 7.2 % | 42.86 | |
Sep2023 | 5.04 % | 38.08 | |
Jun2023 | 3.65 % | 60.79 | |
Mar2023 | 2.27 % | -12.02 | |
Dec2022 | 2.58 % | -34.18 | |
Sep2022 | 3.92 % | - |
MOREPEN LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 29.09 % |
Y-o-Y | 144.83 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2024 | ₹0.71 | 29.09 | |
Mar2024 | ₹0.55 | -12.70 | |
Dec2023 | ₹0.63 | 50.00 | |
Sep2023 | ₹0.42 | 44.83 | |
Jun2023 | ₹0.29 | 81.25 | |
Mar2023 | ₹0.16 | -11.11 | |
Dec2022 | ₹0.18 | -41.94 | |
Sep2022 | ₹0.31 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD